Axel Lambert, MSc

GlaxoSmithKline Biologicals, Belgium

Disclosure(s): GSK: GSK Employee

Poster(s):

• 2139 - Immunogenicity, reactogenicity and safety of a Respiratory Syncytial Virus prefusion F (RSVPreF3) candidate vaccine co-administered with the seasonal quadrivalent influenza vaccine in older adults
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET